Dr. Hall again, keeping my promise to try and keep us all up to date on the latest with the coronavirus or COVID-19. I have some exciting news. The worlds leading expert on communicable diseases is Dr. Raoult. He runs the IHU. This institution is one of the world’s leading centers of expertise in Infectiology and microbiology.
Dr. Raoult was authorized to conduct a clinical trial on the effects of Chloroquine or Plaquenil on the coronavirus. The results of his clinical study came out on March 16th confirming the spectacular therapeutic effects of Plaquenil on COVID-19 have been obtained. Here are the results of the study summarized. The study can be read in full.
Those who did not receive Plaquenil (a hydroxychloroquine drug) remained carriers after 6 days in 90 percent of cases compared to only 25 percent of cases remaining carriers if they received Plaquenil.
The IHU has also been advising that antibiotics be prescribed especially Azithromycin because there is proof that this lowers risk in people with viral infections. Azithromycin is also shown to be effective against a great many viruses although it is an antibiotic. Looking at the comparative percentages of positive carriers with the combination of the Plaquenil and Azithromycin there is an absolutely dramatic decrease in the number of positive carriers. The study also shows a decrease in the viral load of the patients who followed the protocol. In short, if you think you have the Coronavirus – Get tested and if positive, talk to your doctor or emergency room about this treatment protocol with Plaquenil and Azithromycin.
Gautret et al. (2020) Hydroxychloroquine and azithromycin as a treatment of COVID‐19: results of an open‐label non‐randomized clinical trial. International Journal of Antimicrobial Agents – In Press 17 March 2020 – DOI : 10.1016/j.ijantimicag.2020.105949